Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/40141Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Verleye, Arno | - |
| dc.contributor.author | Wijtvliet, Veerle | - |
| dc.contributor.author | ABRAMS, Steven | - |
| dc.contributor.author | Hellemans, Rachel | - |
| dc.contributor.author | Bougrea, Rania | - |
| dc.contributor.author | Massart, Annick | - |
| dc.contributor.author | Pipeleers, Lissa | - |
| dc.contributor.author | Wissing, Karl Martin | - |
| dc.contributor.author | Ariën, Kevin K | - |
| dc.contributor.author | De Winter, Benedicte Y | - |
| dc.contributor.author | Van Damme, Pierre | - |
| dc.contributor.author | Abramowicz, Daniel | - |
| dc.contributor.author | Ledeganck, Kristien J | - |
| dc.date.accessioned | 2023-05-24T08:50:13Z | - |
| dc.date.available | 2023-05-24T08:50:13Z | - |
| dc.date.issued | 2022 | - |
| dc.date.submitted | 2023-05-22T14:32:06Z | - |
| dc.identifier.citation | Nephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/40141 | - |
| dc.description.abstract | Background.Inthegeneralpopulation,theseroconversion rateafterprimaryvaccinationwithtwodosesofanantisevereacuterespiratorysyndromecoronavirus2messenger RNA(mRNA)vaccinereachesnearly100%,withsignificantly higherantibodytitersaftermRNA-1273vaccinationcompared toBNT162b2vaccination.Hereweperformedasystematic reviewandmeta-analysistocomparetheantibodyresponse aftertwo-dosemRNA-1273versusBNT162b2vaccinationin solidorgantransplant(SOT)recipients. Methods.Asystematicliteraturereviewwasperformedusing PubMed,WebofScienceandtheCochraneLibraryand originalresearchpaperswereincludedforameta-analysisto calculatevaccine-specificseroconversionratesforeachofthe mRNAvaccines.Next,thepooledrelativeseroconversionrate wasestimated. Results.Eightstudiesthatdescribedthedevelopmentofantibodiesagainstreceptor-bindingdomain(RBD)and/orspike proteinwereeligibleformeta-analysis.Twoofthesestudies alsoreportedantibodytiters.Themeta-analysisrevealedlower seroconversionratesinSOTrecipientsvaccinatedwithtwo dosesofBNT162b2{44.3%[95%confidenceinterval(CI) 34.1–54.7]}ascomparedwithpatientsvaccinatedwithtwo dosesofmRNA-1273[58.4%(95%CI47.2–69.2)].Therelative seroconversionratewas0.795(95%CI0.732–0.864). Conclusions.Thissystematicreviewandmeta-analysis indicatesthatinSOTrecipients,higherseroconversionrates wereobservedaftervaccinationwithmRNA-1273compared withBNT162b2. | - |
| dc.description.sponsorship | Nofundingwasreceivedtoassistwiththepreparationofthis manuscript. TheauthorswouldliketothankErikSneldersforhis outstandingsecretarialhelp. | - |
| dc.language.iso | en | - |
| dc.publisher | - | |
| dc.rights | The Author(s) 2022.Published by Oxford University Presson behalf of the ERA. Allrights reserved. For permissions, please e-mail: journals.permissions@oup.com. Free access | - |
| dc.title | Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis | - |
| dc.type | Journal Contribution | - |
| dc.identifier.epage | 1575 | - |
| dc.identifier.issue | 8 | - |
| dc.identifier.spage | 1566 | - |
| dc.identifier.volume | 37 | - |
| local.format.pages | 10 | - |
| local.bibliographicCitation.jcat | A1 | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Article | - |
| dc.identifier.doi | 10.1093/ndt/gfac174 | - |
| local.provider.type | CrossRef | - |
| local.uhasselt.international | no | - |
| item.fulltext | With Fulltext | - |
| item.contributor | Verleye, Arno | - |
| item.contributor | Wijtvliet, Veerle | - |
| item.contributor | ABRAMS, Steven | - |
| item.contributor | Hellemans, Rachel | - |
| item.contributor | Bougrea, Rania | - |
| item.contributor | Massart, Annick | - |
| item.contributor | Pipeleers, Lissa | - |
| item.contributor | Wissing, Karl Martin | - |
| item.contributor | Ariën, Kevin K | - |
| item.contributor | De Winter, Benedicte Y | - |
| item.contributor | Van Damme, Pierre | - |
| item.contributor | Abramowicz, Daniel | - |
| item.contributor | Ledeganck, Kristien J | - |
| item.fullcitation | Verleye, Arno; Wijtvliet, Veerle; ABRAMS, Steven; Hellemans, Rachel; Bougrea, Rania; Massart, Annick; Pipeleers, Lissa; Wissing, Karl Martin; Ariën, Kevin K; De Winter, Benedicte Y; Van Damme, Pierre; Abramowicz, Daniel & Ledeganck, Kristien J (2022) Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis. In: Nephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575. | - |
| item.validation | vabb 2024 | - |
| item.accessRights | Open Access | - |
| crisitem.journal.issn | 0931-0509 | - |
| crisitem.journal.eissn | 1460-2385 | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273.pdf | Published version | 772.2 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
12
checked on Dec 1, 2025
WEB OF SCIENCETM
Citations
11
checked on Sep 3, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.